These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35579813)

  • 1. Applying Machine Learning in Distributed Data Networks for Pharmacoepidemiologic and Pharmacovigilance Studies: Opportunities, Challenges, and Considerations.
    Wong J; Prieto-Alhambra D; Rijnbeek PR; Desai RJ; Reps JM; Toh S
    Drug Saf; 2022 May; 45(5):493-510. PubMed ID: 35579813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature.
    Wyss R; Yanover C; El-Hay T; Bennett D; Platt RW; Zullo AR; Sari G; Wen X; Ye Y; Yuan H; Gokhale M; Patorno E; Lin KJ
    Pharmacoepidemiol Drug Saf; 2022 Sep; 31(9):932-943. PubMed ID: 35729705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs.
    Lapeyre-Mestre M; Montastruc F
    Therapie; 2019 Apr; 74(2):209-214. PubMed ID: 30792079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.
    Lai EC; Pratt N; Hsieh CY; Lin SJ; Pottegård A; Roughead EE; Kao Yang YH; Hallas J
    Eur J Epidemiol; 2017 Jul; 32(7):567-582. PubMed ID: 28698923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation.
    Pacurariu A; Plueschke K; McGettigan P; Morales DR; Slattery J; Vogl D; Goedecke T; Kurz X; Cave A
    BMJ Open; 2018 Sep; 8(9):e023090. PubMed ID: 30185579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting coated-nanoparticle drug release systems with perturbation-theory machine learning (PTML) models.
    Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
    Nanoscale; 2020 Jul; 12(25):13471-13483. PubMed ID: 32613998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive modeling of structured electronic health records for adverse drug event detection.
    Zhao J; Henriksson A; Asker L; Boström H
    BMC Med Inform Decis Mak; 2015; 15 Suppl 4(Suppl 4):S1. PubMed ID: 26606038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning in Causal Inference: Application in Pharmacovigilance.
    Zhao Y; Yu Y; Wang H; Li Y; Deng Y; Jiang G; Luo Y
    Drug Saf; 2022 May; 45(5):459-476. PubMed ID: 35579811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Query Workflow Design to Perform Automatable Distributed Regression Analysis in Large Distributed Data Networks.
    Her QL; Malenfant JM; Malek S; Vilk Y; Young J; Li L; Brown J; Toh S
    EGEMS (Wash DC); 2018 May; 6(1):11. PubMed ID: 30094283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invited Commentary: Go BIG and Go Global-Executing Large-Scale, Multisite Pharmacoepidemiologic Studies Using Real-World Data.
    Maro JC; Toh S
    Am J Epidemiol; 2022 Jul; 191(8):1368-1371. PubMed ID: 35597819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory pharmacovigilance with machine learning in big patient data: A focused scoping review.
    Kaas-Hansen BS; Gentile S; Caioli A; Andersen SE
    Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):233-241. PubMed ID: 36541054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.
    ; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370
    [No Abstract]   [Full Text] [Related]  

  • 14. c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children - A c4c expert group white paper.
    Aurich B; Apele-Freimane D; Banaschewski T; Chouchana L; Day S; Kaguelidou F; Kelly LE; Kindblom JM; Neubert A; Wong ICK
    Br J Clin Pharmacol; 2022 Dec; 88(12):4997-5016. PubMed ID: 34699077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can the quality of medical data in pharmacovigilance, pharmacoepidemiology and clinical studies be guaranteed?
    Alla F; Rosilio M; Funck-Brentano C; ; Barthélémy P; Brisset S; Cellier D; Chassany O; Demarez JP; Diebolt V; Francillon A; Gambotti L; Hannachi H; Lechat P; Lemaire F; Lièvre M; Misse C; Nguon M; Pariente A; Rosenheim M; Weisslinger-Darmon N
    Therapie; 2013; 68(4):209-23. PubMed ID: 23981258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training Augmented Intelligent Capabilities for Pharmacovigilance: Applying Deep-learning Approaches to Individual Case Safety Report Processing.
    Abatemarco D; Perera S; Bao SH; Desai S; Assuncao B; Tetarenko N; Danysz K; Mockute R; Widdowson M; Fornarotto N; Beauchamp S; Cicirello S; Mingle E
    Pharmaceut Med; 2018; 32(6):391-401. PubMed ID: 30546259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoepidemiology and Big Data Analytics: Challenges and Opportunities when Moving towards Precision Medicine.
    Burden AM
    Chimia (Aarau); 2019 Dec; 73(12):1012-1017. PubMed ID: 31883553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges.
    Lai EC; Ryan P; Zhang Y; Schuemie M; Hardy NC; Kamijima Y; Kimura S; Kubota K; Man KK; Cho SY; Park RW; Stang P; Su CC; Wong IC; Kao YY; Setoguchi S
    Clin Epidemiol; 2018; 10():875-885. PubMed ID: 30100761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
    Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media.
    Comfort S; Perera S; Hudson Z; Dorrell D; Meireis S; Nagarajan M; Ramakrishnan C; Fine J
    Drug Saf; 2018 Jun; 41(6):579-590. PubMed ID: 29446035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.